Human RAC-Alpha Serine/Threonine-Protein Kinase (AKT1) Enzyme

Human RAC-Alpha Serine/Threonine-Protein Kinase (AKT1) Enzyme (Active) is a recombinant protein produced in Human. This gene encodes one of the three members of the human AKT serine-threonine protein kinase family which are often referred to as protein kinase B alpha, beta, and gamma. These highly similar AKT proteins all have an N-terminal pleckstrin homology domain, a serine/threonine-specific kinase domain and a C-terminal regulatory domain. These proteins are phosphorylated by phosphoinositide 3-kinase (PI3K). AKT/PI3K forms a key component of many signalling pathways that involve the binding of membrane-bound ligands such as receptor tyrosine kinases, G-protein coupled receptors, and integrin-linked kinase. These AKT proteins therefore regulate a wide variety of cellular functions including cell proliferation, survival, metabolism, and angiogenesis in both normal and malignant cells. AKT proteins are recruited to the cell membrane by phosphatidylinositol 3,4,5-trisphosphate (PIP3) after phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) by PI3K. Subsequent phosphorylation of both threonine residue 308 and serine residue 473 is required for full activation of the AKT1 protein encoded by this gene. Phosphorylation of additional residues also occurs, for example, in response to insulin growth factor-1 and epidermal growth factor. Protein phosphatases act as negative regulators of AKT proteins by dephosphorylating AKT or PIP3. The PI3K/AKT signalling pathway is crucial for tumor cell survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating AKT1 which then phosphorylates and inactivates components of the apoptotic machinery. AKT proteins also participate in the mammalian target of rapamycin (mTOR) signalling pathway which controls the assembly of the eukaryotic translation initiation factor 4F (eIF4E) complex and this pathway, in addition to responding to extracellular signals from growth factors and cytokines, is disregulated in many cancers. Mutations in this gene are associated with multiple types of cancer and excessive tissue growth including Proteus syndrome and Cowden syndrome 6, and breast, colorectal, and ovarian cancers. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020].

Target	RAC-Alpha Serine/Threonine-Protein Kinase (AKT1)
Origin	Human
Expression	Recombinant
Host	Insect
Recommended dilutions	Optimal dilutions/concentrations should be determined by the end user.
Form	Liquid
Storage	Store at 4 °C for short term. Store at -20 °C for long term. Avoid repeated freeze/thaw cylces.
UniProt Primary AC	P31749 (UniProt, ExPASy)
UniProt Secondary AC	B2RAM5, B7Z5R1, Q9BWB6
UniProt Entry Name	AKT1_HUMAN
KEGG	hsa:207
String	9606.ENSP00000451828
Activity	Active
Biological Activity	20,000 U/mg One Unit (U) is defined as 1 pmol/min transferred to synthetic peptide RPRAATF at 30°C
Availability	Shipped within 5-10 working days.
Note	This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.

Research Articles on RAC-Alpha Serine/Threonine-Protein Kinase (AKT1)

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue